Pipeline
Our goalsBuilding the foundation for scalable growth
In 2025, we are advancing both our research and commercialization efforts. To support this, we need a dedicated space to generate key data, strengthen our intellectual property, and position the company for growth.
While we plan to apply for funding from BII and other foundations, our immediate focus is securing the right facility to conduct our research and prepare for the next stage of development.
We are working on several pipelines in immuno-oncology. All of the programs are in the pre-clinical stage.
